Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × The Diagnosis Was ALK Positive NSCLC × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2005 Lung Neoplasms 939 Small Cell Lung Carcinoma 357 Adenocarcinoma of Lung 139 Mesothelioma, Malignant 110 Neoplasms 101 Breast Neoplasms 95 Brain Neoplasms 92 Neoplasm Metastasis 79 NSCLC 63 Melanoma 63 Mesothelioma 61 Colorectal Neoplasms 59 Adenocarcinoma, Bronchiolo-Alveolar 49 Thymoma 46 Pancreatic Neoplasms 46 Head and Neck Neoplasms 39 Ovarian Neoplasms 38 Carcinoma, Renal Cell 38 Carcinoma 32 Adenocarcinoma 32 Sarcoma 31 Prostatic Neoplasms 31 Stomach Neoplasms 29 Squamous Cell Carcinoma of Head and Neck 28 Esophageal Neoplasms 28 Pleural Effusion, Malignant 27 Recurrence 26 Uterine Cervical Neoplasms 23 Urinary Bladder Neoplasms 22

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05178511 2022-01-05

ERSGATR

Sun Yat-sen University

Phase 2 Unknown

The Diagnosis Was ALK Positive NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡